Bill Text: NY S01237 | 2019-2020 | General Assembly | Introduced

New York Senate Bill 1237 (Prior Session Legislation)

Introduced

Bill Title: Requires the commissioner of health to develop guidelines for the prescription of opioid antagonists.

Spectrum: Partisan Bill (Republican 2-0)

Status: (Introduced - Dead) 2020-01-08 - REFERRED TO HEALTH [S01237 Detail]

Download: New_York-2019-S01237-Introduced.html



                STATE OF NEW YORK
        ________________________________________________________________________
                                          1237
                               2019-2020 Regular Sessions
                    IN SENATE
                                    January 11, 2019
                                       ___________
        Introduced  by  Sens. AMEDORE, AKSHAR -- read twice and ordered printed,
          and when printed to be committed to the Committee on Health
        AN ACT to amend the public health law,  in  relation  to  requiring  the
          commissioner  of  health  to develop guidelines for the prescribing of
          opioid antagonists
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
     1    Section  1.  The  public health law is amended by adding a new section
     2  3346 to read as follows:
     3    § 3346. Guidelines for the prescribing of opioid antagonists. 1.   The
     4  commissioner shall adopt guidelines for the prescribing of opioid antag-
     5  onists  that are applicable to all licensed health care providers in the
     6  state who are authorized to prescribe an opioid analgesic.  Such  guide-
     7  lines must address:
     8    (a)  prescribing  an  opioid antagonist to a patient to whom an opioid
     9  medication is also prescribed; and
    10    (b) identifying patients at risk of an  opioid-related  drug  overdose
    11  and prescribing an opioid antagonist to that patient or to a person in a
    12  position to administer the opioid antagonist to that patient.
    13    2.  In  adopting guidelines under this section, the commissioner shall
    14  consult with the state board of pharmacy as well as materials  published
    15  by,  but  not limited to, the substance abuse and mental health services
    16  administration of the United  States  department  of  health  and  human
    17  services  and  other  appropriate  materials, including medical journals
    18  subject to peer review and publications by medical professional  associ-
    19  ations.
    20    3.  The commissioner is authorized to promulgate rules and regulations
    21  necessary for the implementation of this section.
    22    § 2. This act shall take effect on the one hundred eightieth day after
    23  it shall have become a law. Effective immediately, the addition,  amend-
    24  ment and/or repeal of any rule or regulation necessary for the implemen-
    25  tation  of  this act on its effective date are authorized to be made and
    26  completed on or before such date.
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD01603-01-9